ZOOM First Impressions

Self Esteem Clinical Trial

Official title:

Effects of Video Conferencing on First Impressions and Attractiveness

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT05739721
• Other study ID #: ZOOM-SD-2021
• Status: Withdrawn
• Phase: N/A
• Start date: November 1, 2021
• Est. completion date: November 1, 2022

Study information

• Verified date: February 2023
• Source: DeNova Research
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Participants (random) will have a conversation with each other over zoom initially with their cameras off and then rate each other on attractiveness, first impressions, and self-esteem. Then both participants will turn their cameras back on and have another conversion and then again rate each other. The ratings are confidential and will not be shared with the other person. Two months later the participants will come to the study clinic office and have an in-person conversation with someone new and rate each other.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: November 1, 2022
• Est. primary completion date: October 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 39 Years

Eligibility

Inclusion Criteria:

1. Males and females of ages 21-39.

2. Subjects that understand the purpose and aspects of the study, freely sign the consent and complete the required treatment and follow up visit.

3. Subjects must all be able to speak English fluently.

4. Subjects must have access to video camera technology.

5. Fully Vaccinated against covid-19

Exclusion Criteria:

1. Participants younger than 21 or older than 40 will not be included.

2. Subjects who are pregnant or nursing.

3. Imprisoned populations.

4. Subjects who are unable to travel to the clinic.

5. Subjects that do not understand the purpose and aspects of the study, do not sign the consent and do not complete the required virtual session and follow-up visit will also be excluded.

6. Any subject that is not fully vaccinated against covid-19

Related Conditions & MeSH terms

• Self Esteem

Intervention

Behavioral:
• Attractiveness
Visual attractiveness scale 0-7
• Self-Esteem
Self Esteem scale
• Trustworthiness
Trustworthiness scale 0-7

Locations

Country	Name	City	State
United States	DeNova Research	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
DeNova Research

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	First Impressions	The defined categories of first impressions include: Social skills, academic performance, dating success, occupational success, attractiveness, financial success, relationship success, and athletic success. The scale ranges from a score of 1 (less desirable) to 10 (most desirable). Scores closer to 10 signify a more positive outcome.	8 weeks
Primary	Trustworthiness scale	Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.	8 weeks
Primary	Overall Attractiveness	Scale 0 (disagree) - 7 (agree). Scores closer to 7 signify a more positive outcome.	8 weeks
Secondary	Self-Esteem	The Rosenberg Self-Esteem Scale is a 10-item self-report measure of global self-esteem. It consists of 10 statements related to overall feelings of self-worth or self-acceptance. The items are answered on a four-point scale ranging from strongly agree, agree, disagree, and strongly disagree.	8 weeks